FR2279421A1 - Application d'enzymes proteolytiques comme auxiliaires de la prophylaxie par antibiotiques des blessures contaminees - Google Patents

Application d'enzymes proteolytiques comme auxiliaires de la prophylaxie par antibiotiques des blessures contaminees

Info

Publication number
FR2279421A1
FR2279421A1 FR7442067A FR7442067A FR2279421A1 FR 2279421 A1 FR2279421 A1 FR 2279421A1 FR 7442067 A FR7442067 A FR 7442067A FR 7442067 A FR7442067 A FR 7442067A FR 2279421 A1 FR2279421 A1 FR 2279421A1
Authority
FR
France
Prior art keywords
injuries
contaminated
auxiliary
application
proteolytic enzymes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7442067A
Other languages
English (en)
Other versions
FR2279421B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sutures Inc
Original Assignee
Sutures Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sutures Inc filed Critical Sutures Inc
Publication of FR2279421A1 publication Critical patent/FR2279421A1/fr
Application granted granted Critical
Publication of FR2279421B1 publication Critical patent/FR2279421B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21004—Trypsin (3.4.21.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7442067A 1974-04-29 1974-12-19 Application d'enzymes proteolytiques comme auxiliaires de la prophylaxie par antibiotiques des blessures contaminees Granted FR2279421A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/465,309 US3940478A (en) 1974-04-29 1974-04-29 Proteolytic enzymes as adjuncts to antibiotic prophylaxis of contaminated wounds

Publications (2)

Publication Number Publication Date
FR2279421A1 true FR2279421A1 (fr) 1976-02-20
FR2279421B1 FR2279421B1 (fr) 1978-07-28

Family

ID=23847273

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7442067A Granted FR2279421A1 (fr) 1974-04-29 1974-12-19 Application d'enzymes proteolytiques comme auxiliaires de la prophylaxie par antibiotiques des blessures contaminees

Country Status (4)

Country Link
US (1) US3940478A (fr)
JP (1) JPS50140619A (fr)
FR (1) FR2279421A1 (fr)
IT (1) IT1036563B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2448903A1 (fr) * 1979-02-19 1980-09-12 Martin Henri Medicament nouveau a base d'agents antimicrobiens, d'enzymes, d'anti-inflammatoires, d'anesthesique local, d'agents keratolytiques, d'agents mucolytiques et d'au moins un emulsionnant

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2150833B (en) * 1983-12-08 1987-04-15 Ceskoslovenska Akademie Ved Proteolytic wounds dressing
US5387517A (en) * 1994-03-23 1995-02-07 Ethicon, Inc. Thiol activated protease from stem bromelain for treating devitalized tissue
US5883074A (en) * 1995-02-08 1999-03-16 Microcide Pharmaceuticals, Inc. Potentiators of antibacterial agents
US6407056B1 (en) 1996-07-12 2002-06-18 Johnson & Johnson Consumer Companies, Inc. Methods for altering hair growth and hair pigmentation by apoptosis in the follicular papillae and compositions therefor
US6413512B1 (en) * 1998-02-13 2002-07-02 National Enzyme Company Composition and method for treating disease by increasing activated α2 macroglobulin in the blood and extravascular tissue
US6187822B1 (en) * 1999-06-11 2001-02-13 University Of Medicine & Dentistry Of Nj Wound treatment through inhibition of adenosine diphosphate ribosyl transferase
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US20070053895A1 (en) 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US7048926B2 (en) * 2000-10-06 2006-05-23 Affinium Pharmaceuticals, Inc. Methods of agonizing and antagonizing FabK
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US6861009B1 (en) * 2003-03-06 2005-03-01 E. Greg Leist Deicing compositions and methods of use
US20060169947A1 (en) * 2003-03-06 2006-08-03 Leist E G Deicing compositions and methods of use
US20060198838A1 (en) * 2004-09-28 2006-09-07 Fallon Joan M Combination enzyme for cystic fibrosis
US20080058282A1 (en) * 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
US20070116695A1 (en) * 2005-09-21 2007-05-24 Fallon Joan M Pharmaceutical preparations for attention deficit disorder, attention deficit hyperactivity disorder and other associated disorders
JP2009523120A (ja) * 2005-12-09 2009-06-18 アールエックス３ ファーマシューティカルズ インコーポレイテッド 抗生物質の相乗効果の同定法と応用法
JP2010510310A (ja) 2006-11-22 2010-04-02 スタンダード バイオロジックス インコーポレイテッド コウジカビプロテアーゼを使用する処置の方法
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) * 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
PL2318035T3 (pl) * 2008-07-01 2019-10-31 Curemark Llc Sposoby i kompozycje do leczenia objawów zaburzeń neurologicznych i zaburzeń zdrowia psychicznego
US10776453B2 (en) * 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
CA2747703C (fr) 2009-01-06 2021-06-15 Curemark Llc Compositions et methodes de traitement ou de prevention d'infections par e. coli
JP5684725B2 (ja) * 2009-01-06 2015-03-18 キュレロン リミテッド ライアビリティ カンパニー 黄色ブドウ球菌感染の治療または予防のための組成物および方法ならびに表面上にいる黄色ブドウ球菌の根絶または低減のための組成物および方法
AU2015252099B2 (en) * 2009-01-06 2017-08-10 Galenagen, Llc Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
AU2012245287B2 (en) 2011-04-21 2017-04-13 Curemark, Llc Compounds for the treatment of neuropsychiatric disorders
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2036E (fr) * 1903-04-29 1903-12-16 Moteurs Et Automobiles Herald Frein agissant dans les deux sens de marche, pour voitures automobiles et autres destinations
US2973300A (en) * 1956-05-07 1961-02-28 American Home Prod Process for making antibiotic-enzyme topical film-forming compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2448903A1 (fr) * 1979-02-19 1980-09-12 Martin Henri Medicament nouveau a base d'agents antimicrobiens, d'enzymes, d'anti-inflammatoires, d'anesthesique local, d'agents keratolytiques, d'agents mucolytiques et d'au moins un emulsionnant

Also Published As

Publication number Publication date
FR2279421B1 (fr) 1978-07-28
IT1036563B (it) 1979-10-30
US3940478A (en) 1976-02-24
JPS50140619A (fr) 1975-11-11
AU7788175A (en) 1976-08-05

Similar Documents

Publication Publication Date Title
FR2279421A1 (fr) Application d'enzymes proteolytiques comme auxiliaires de la prophylaxie par antibiotiques des blessures contaminees
BR7902794A (pt) Composicao elastomerica de silicona
FR2302750A1 (fr) Composition de gel de traitement de l'air
FR2342072A1 (fr) Composition enzymatique pour le traitement de la cataracte
FR2293485A1 (fr) Compositions lubrifiantes ameliorees par l'addition de copolymeres greffes
IT1039745B (it) Procedimento per la purificazione di eilende ossido
IT1069277B (it) Procedimento ed impianto per la depurazione di alogenosilani
BE881749A (fr) Procede d'hydrolyse de compositions chlorosiliciees poly-fonctionnelles
ES454964A1 (es) Un procedimiento para la preparacion de acido 7-d-(-)-alfa- amino-alfa-(p-hidroxifenilacetamido) desacetoxicefalospora- nico, hidrato o sales farmaceuticamente aceptables del mis- mo.
IT7947542A0 (it) Composizione di gomma di elevata durezza ed elevato modulo contenente 1,2-polibutadiene
BE834026A (fr) Procede de preparation des carbonates d'alkylene
IT1062606B (it) Procedimento ed impianto nonche composizione catalitica per la ossiclorurazione di etilene
IT8024633A0 (it) Composizione di gomma siliconica per guarnizioni di semiassi.
BE828972A (fr) Procede de fabrication de maltose par l'emploi d'un enzyme
BE828790A (fr) 2-pyrazinemethanols utilises comme agents protecteurs des plantes
IT7849692A0 (it) Procedimento per la purificazione di urochinasi
IT1122111B (it) Procedimento per la purificazione di resorcina grezza
IT8048641A0 (it) Procedimento di depurazione dell'antibiotico spectinomicina
FR2301542A1 (fr) Composition de scellement durcissable en l'absence d'air
BE808893A (fr) Purification de l'antraquinone
ZA764225B (en) Distillative purification of 2,5-dioxo-1-oxa-2-phospholanes
CA1026141A (fr) Mise au registre de compositions en plusieurs galees
BE828185A (fr) Purification de d-aminoacide oxydase
FR2323394A1 (fr) Nouvelles procidines utiles comme inhibiteurs de proteases
AU484105B2 (en) Proteolytic enzymes as adjuncts to antibiotic prophylaxis of contaminated wounds

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse